We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$45.3M
Cap. Flow
+$31.6M
Cap. Flow %
2.69%
Top 10 Hldgs %
18.09%
Holding
582
New
63
Increased
234
Reduced
235
Closed
31
Avg Time Held
2.9 quarters
Top 10 Avg Time Held
2.9 quarters
Top 20 Avg Time Held
2.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.4%
2 Technology 11.45%
3 Financials 4.01%
4 Communication Services 3.03%
5 Consumer Discretionary 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QQQX icon
576
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.53B
– –
-9,242
Closed -$260K –
RWT icon
577
Redwood Trust
RWT
$383M
– –
-10,000
Closed -$53.4K –
SG icon
578
Sweetgreen
SG
$1.19B
– –
-169,274
Closed -$1.06M –
SHV icon
579
iShares 0-1 Year Treasury Bond ETF
SHV
$23.5B
– –
-3,227
Closed -$357K –
THLV icon
580
THOR Low Volatility ETF
THLV
$55.5M
– –
-9,469
Closed -$284K –
TT icon
581
Trane Technologies
TT
$105B
– –
-480
Closed -$214K –
OKLO icon
582
Oklo
OKLO
$5.91B
– –
-1,460
Closed -$201K –

Similar funds

Sovran Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Sovran Advisors held 582 positions worth $1.18B, up 4% from $1.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sovran Advisors's Q4 2025 filing shows 63 new, 234 increased, 235 reduced and 31 closed positions. Its largest new stake was CoreWeave: 70,438 shares worth $6.69M. The largest sale was Ionis Pharmaceuticals, an estimated $11.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 72% a quarter earlier, followed by Technology and Financials.

  • Sovran Advisors's largest Q4 2025 buy was CoreWeave: 70,438 shares worth $6.69M.
  • Sovran Advisors added most to Broadcom in Q4 2025, an estimated $6M increase.
  • Sovran Advisors's biggest Q4 2025 reduction was PIMCO RAFI Multi-Factor International Equity ETF, cutting an estimated $4.07M.
  • Sovran Advisors fully exited Ionis Pharmaceuticals in Q4 2025, selling an estimated $11.2M.
  • Sovran Advisors's ten largest holdings make up 18% of its $1.18B portfolio in Q4 2025.
  • Sovran Advisors opened 63 new positions and closed 31 in Q4 2025.
  • Sovran Advisors's portfolio value rose 4% quarter-over-quarter to $1.18B.

Based on Sovran Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.